ACE and Hyperglycemia: Treatment of CKD recommends the control of traditional risk factors such as AH, hyperglycemia, and dyslipidemia with common pharmacological tools, i.e., angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blocker (ARB) and statins.